Therapeutic Dosing of Cloxacillin for MSSA Impetigo

Guideline-Based Antibiotic Selection

• The Infectious Diseases Society of America (IDSA) guidelines recommend dicloxacillin (cloxacillin's close analog) or cephalexin as first-line agents for impetigo when MSSA is suspected or confirmed, given that most S. aureus isolates from impetigo are methicillin-susceptible, with a treatment duration of 7 days for uncomplicated impetigo 1, 2

Standard Dosing Regimens

• For impetigo caused by methicillin-susceptible Staphylococcus aureus (MSSA), cloxacillin should be dosed at 250-500 mg orally four times daily in adults (or 25 mg/kg/day divided into four doses in children) for 7 days 1, 2

Clinical Context for MSSA Impetigo

• The IDSA guidelines mention dicloxacillin specifically, but cloxacillin is pharmacologically equivalent and widely used internationally as a penicillinase-resistant penicillin, remaining the antibiotic of choice for serious MSSA infections due to its bactericidal activity, tissue distribution, and safety profile 1, 2

Important Caveats

• If cultures yield streptococci alone, oral penicillin (not cloxacillin) becomes the preferred agent, as per the IDSA guidelines 1, 2
• Beta-lactams including cloxacillin are completely ineffective against methicillin-resistant strains and should never be used when MRSA is suspected, according to the IDSA guidelines 1, 2